Concepedia

Brenda F. Baker

BF

Statistics

Publications

59

Citations

9.4K

H-Index

42

Active since

1985

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of California San Diego

Amsterdam UMC Location University of Amsterdam

University of Amsterdam

Indiana University – Purdue University Indianapolis

Brenda F. Baker is an author at Ionis Pharmaceuticals (United States) specializing in pharmacology, antisense rnas, and life sciences.

ORCID

Publications per year

1985–2022

59

Publications

59

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

, , +16

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Mark J. Graham, Richard Lee, Teresa Brandt et al. · New England Journal of Medicine · 2017 · 581 citations · Full text

, , +14

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

Daniel Gaudet, Veronica Alexander, Brenda F. Baker et al. · New England Journal of Medicine · 2015 · 528 citations · Full text

, , +14

Targeting APOC3 in the Familial Chylomicronemia Syndrome

Daniel Gaudet, Diane Brisson, Karine Tremblay et al. · New England Journal of Medicine · 2014 · 493 citations · Full text

, , +17

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Sotirios Tsimikas, Nicholas J. Viney, Steven G. Hughes et al. · The Lancet · 2015 · 464 citations

, , +7

1–5 of 59